Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...
The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs Ozempic, Wegovy and Rybelsus, for the ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...